Related Experiment Video
Updated: Jul 4, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Headache therapy with neuronal stabilising drugs.
Bruno Colombo1, Dacia Dalla Libera, Pietro Oreste Annovazzi
1Department of Neurology Headache Research Unit, IRCCS San Raffaele University Vita-Salute, Via Olgettina 48, 20100 Milan, Italy. colombo.bruno@hsr.it
Summary
Neuronal stabilizing drugs, like Valproate and Topiramate, are effective for migraine prophylaxis. These antiepileptic medications help reduce migraine attack frequency, severity, and duration.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a common episodic neurological disorder impacting quality of life.
- Effective prophylaxis is crucial for managing migraine severity, frequency, and disability.
- Migraine involves complex pain modulation pathways, including the trigeminovascular system.
Purpose of the Study:
- To review the efficacy of antiepileptic drugs (neuronal stabilizing drugs, NSD) in migraine prophylaxis.
- To highlight the role of neuronal stabilization in managing episodic headache disorders.
Main Methods:
- Review of randomized double-blind, placebo-controlled trials.
- Analysis of studies investigating specific antiepileptic drugs for migraine prevention.
Main Results:
- Valproate, Topiramate, and Gabapentin are identified as effective options for migraine preventive therapy.
- These neuronal stabilizing drugs have demonstrated significant efficacy in clinical trials.
- Positive trial outcomes support the use of these agents in reducing migraine burden.
Conclusions:
- Neuronal stabilization represents a pivotal therapeutic approach for headache management.
- Antiepileptic drugs are increasingly recommended for migraine prophylaxis due to proven effectiveness.
- Further research may explore the mechanisms underlying neuronal stabilization in migraine treatment.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...